A worrisome by-product of modern industrial society is the massive problem of toxic waste disposal. The potential for such wastes to cause health damage in exposed human populations requires the performance of epidemiologic investigations to assess relationships between toxic exposure and possible health consequences, clinical or subclinical. Although such investigations are conceptually simple and involve straightforward concepts of cause and effect, their success entails not only complex and expensive technical assessment of exposure, but also close attention to the statistical and methodologic requirements of effective epidemiologic design. This paper concerns these latter requirements and presents as illustrations several toxic waste health studies recently conducted in the United States (Table 1) .
A general feature of such studies is the sheer diversity of situations in which toxic wastes can be involved. No two situations, and therefore no two studies, are exactly the same. Differences, in fact, can be extreme, ranging from the common stereotype of a drum-filled dump site to the widespread dispersal of waste material. The five toxic waste situations described in Table 1 illustrate this diver-sity, both in waste materials and in exposure settings. The first two listed (the Love Canal and the Melvin Wade dumps) constitute discrete and relatively organized dumping. The wastes consisted mostly of organic materials, with human contact being by diverse routes at Love Canal (1) and by direct contact, fire, and explosion at the Wade site (unpublished data, Centers for Disease Control, Atlanta, GA, 1979) . In Woburn, MA, toxic chemical wastes remained from past industries involved in tanning and in the production of arsenical pesticides (2) . Potential exposure to both organic and inorganic materials may have occurred by both direct and waterborne routes (from contaminated local wells that provided drinking water). In Triana, AL, waste material from the manufacture of DDT pesticides was dumped in a local stream (3, 4) . High levels of DDT congeners developed in fish in the stream and in the local rural population consuming the fish. In Bloomington, IN, a local manufacturer of electric equipment discharged wastes containing polychlorinated biphenyls (PCB) into the city sewer system (5). PCB-containing sludge from the sewage treatment plant was then used for organic gardening by members of the local community.
In the first three settings, since levels of chemicals in exposed persons could not be measured directly, potential health effects had to be assessed indirectly. At the Love Canal, this took the form of extensive questionnaire surveys as well as a review In the other two settings, Triana and Bloomington, levels of persistent chemicals (DDT/DDE, PCB) in exposed persons could be measured. Elevated levels were found in the first instance, but in the second it appeared. that contact with PCBcontaminated sludge used for gardening purposes did not increase body levels ofthe chemical, although increased levels were seen in workers at the electrical manufacturing plant. Neither setting has been clearly associated with clinical illness.
Requirements of Epidemiologic Studies
Epidemiologic studies in settings such as these, regardless of their diversity, consist of three fundamental phases: (1) assessing the nature of toxic materials present, (2) understanding how human exposure to these toxins might occur and (3) evaluating potential biologic effects. Adequate information in each of these phases is critical for the success of any epidemiologic study.
Toxins
The first step in any toxic waste study is 
Biologic Effect
The prime objective in epidemiologic studies is to associate particular exposures with potential biologic effects and thus to define cause-effect relationships. Since this process is by nature an indirect assessment of etiology, it is highly dependent on the precision and specificity of observations recorded both for potential exposure and for potential biologic effect. It gains particular power if doseresponse relationships can be shown, that is, if increasing levels of exposure are associated with increasing frequency of the biologic effect.
To assess the presence or absence of etiologic relationships, the epidemiologist must be aware of three particular difficulties which can severely limit the power of an epidemiologic investigation ( Table  2 ). The first of these involves the size of the population needed for study to demonstrate a given health effect with a given degree of power. This depends both on the degree of exposure involved (dose) and on the expected baseline frequency of the particular health effect. If the health outcome to be assessed is relatively rare, the population to be studied will need to be relatively large.
The second difficulty is that of long or variable latency. Particularly at lower levels of toxic exposure, health effects such as cancer cannot be observed (if in fact they are caused by the particular exposure) until years later. This requires that the study design either allow for long-term health follow-up or seek some subclinical biologic marker which can predict eventual cancer risk. Since no such markers have been developed (and their development involves a formidable array of methodologic obstacles), one is left either with prospects of long-continued study or with studies of current cancer occurrence in the instance where exposure has already existed over a span of years.
The third issue is that of competing causes, or expressed differently, the clinical nonspecificity of biologic effects under study. To the epidemiologist this means adjustment for potential confounding factors in a study. Since, as mentioned above, it is exceedingly unusual for a particular biologic effect to be the specific and exclusive result of particular toxic exposure, study design must allow for data to be collected about other exposures that might also give rise to the effect and about variables which might indirectly reflect degree of exposure to any or all such risk factors. In practical terms, this means collecting data regarding past occupational exposures, personal exposures such as cigarette smoking or use of alcohol or drugs, and personal characteristics such as sex, race, age, and socioeconomic status which may predict levels of risk for specific health outcomes. The more variables a study addresses, of course, the more complex its eventual analysis becomes, and the greater the size of the population needed for adequately assessing health effects.
These various principles may best be illustrated by a brief account of the Love Canal toxic waste Chemicals had spread through the soil into adjoining residential lots, facilitated by seepage of surface water into the Canal. In the spring and summer of 1978, as engineering plans developed to correct this problem, epidemiologic studies were begun to assess potential relationships between health patterns in the community and exposure to chemicals from the Canal.
The population at risk was first defined as persons living in the first two "rings" of homes adjoining the east and west sides of the Canal (99 dwellings, about 300 persons). Attention later extended to the general nearby community of about 4000 persons, some living at sites where natural surface drainage patterns, antedating community development, might conceivably facilitate trans-soil seepage of chemicals. To define actual exposure levels in these populations, particularly adjacent to the Canal, the New York State Department of Health (NYSDH) performed extensive environmental chemical tests (soil, water, and indoor and outdoor air). Potential oncogenic, mutagenic and teratogenic chemicals (benzene, chlorobenzene and others) were identified in the Canal. Low-level contamination with such chemicals was also clearly evident at various sites in the first two rings of homes, but only in trace amounts elsewhere (including homes along natural drainage paths) (1). The results of further environmental tests are still being analyzed.
NYSDH collected health information through an interview survey of local residents, backed by a review of medical records (6, 7) . Information was sought on a wide range of conditions. No unusual patterns were noted, except possibly with respect to certain reproductive effects. Special attention was given to reproductive outcomes, since latency considerations and limited sample size precluded immediate conclusions regarding possible low-dose oncogenic effects, and since potential fetal sensitivity to toxic effects encouraged a focus on pregnancy.
A summary of pregnancy outcomes (abortion, birth defects and low birth weight) is shown in Table 3 , both for women living close to the Canal (first two rings) and for women living elsewhere in the Canal area, some where risk of Canal seepage was possibly increased. No clear increased risk was seen for any of the three pregnancy outcomes in women living next to the Canal. Although an increased frequency of low birth weight in women from homes with possible seepage risk suggested a toxic effect, the finding does not correspond well with NYSDH environmental test results.
In a later epidemiologic study, NYSDH examined cancer incidence patterns in the Love Canal area (8) . Rates in the census tract containing the Love Canal were compared with rates in other tracts in Niagara Falls. No consistent differences were found, although some lung cancer rates in women were elevated. Specifically, no increases over time were seen for liver tumors or for hematopoietic malignancies (leukemia, lymphoma).
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The aAdapted from NYSDH data (7).
bResidences on 97th and 99th Streets which border the Canal site on east and west.
causes), interpretation of the Love Canal findings remains difficult. This is particularly so for abortions and birth defects, since one must reckon with a considerable likelihood of bias in observer recall. Since common and cause-specific clinical markers for potential toxic waste health effects are lacking, further studies of exposed populations will need to focus both on the sustained long-term follow-up of health effects and, at the same time, on the development of subclinical indicators for precisely predicting risk of eventual illness. Neither approach is simple. Long-term population follow-up studies entail not only considerable expense and logistic commitment but also serious ethical issues. Although subclinical markers, such as cytogenetic or mutagenic tests, have received much attention in recent years, they are not ready for field application. A vivid illustration of this gap was the unsuccessful attempt to relate cytogenetic findings in Love Canal residents to concrete clinical predictions (9) . Until such cellular or subcellular tests can be clearly correlated with specific disease risks and with other biologic markers, their use in epidemiologic studies remains limited.
